While semaglutide reduces appetite, it is still important to eat enough nutrients to support your metabolism, energy levels, and overall health
In addition, you must meet one of the three clinical criteria set by CMS, measured at the time you start GLP-1 therapy: BMI of 35 or higher (and age 18 or older), or BMI of 30 or higher (and age 18 or older), plus one of the following: heart failure with preserved ejection fraction, uncontrolled high blood pressure (systolic above 140 or diastolic above 90 despite treatment with two blood pressure medications), or chronic kidney disease stage 3a or above, or BMI of 27 or higher (and age 18 or older), plus one of the following: prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease If you take a GLP-1 for another condition, the Bridge is not for you
As patients lose weight, blood pressure often naturally decreases, creating a paradoxical benefit: while semaglutide itself may cause mild blood pressure elevation in some individuals during early weeks, the subsequent weight loss typically produces a net reduction in systolic and diastolic readings
Skin discoloration may look red on light skin and brown, purple or grey on darker skin
Many people report seeing improvements in their skins tone and texture after just a few treatments, with results that can last for weeks or even months
The math is not complicated once you understand the relationships, but a single miscalculation can lead to dramatically wrong doses
